💨 Abstract

Australia's government has asserted that it will not compromise its policy of subsidizing certain medicines through the Pharmaceutical Benefits Scheme (PBS), even as U.S. President Trump's executive order aims to lower domestic drug prices by potentially equalizing prices with other countries. Australia advocates for open, rules-based trade and has resisted previous U.S. efforts to alter the PBS during free trade negotiations. Meanwhile, European governments are evaluating the potential impact of Trump's order.

Courtesy: theprint.in